NCT00630357View on ClinicalTrials.gov

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Epilepsy
Interventions
DRUG

Levetiracetam (Keppra)

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY